BRIEF published on 01/19/2026 at 13:01, 3 months 30 days ago Viromed Medical AG franchit une étape importante avec une étude pulmonaire ex vivo Recherche Médicale Viromed Medical AG Technologie Du Plasma Froid Étude Pulmonaire Ex Vivo Progrès Pharmaceutique
BRIEF published on 01/19/2026 at 13:01, 3 months 30 days ago Viromed Medical AG Achieves Milestone with Ex-Vivo Lung Study Medical Research Viromed Medical AG Cold Plasma Technology Ex-vivo Lung Study Pharmaceutical Advancement
PRESS RELEASE published on 01/19/2026 at 12:56, 3 months 30 days ago Correction of a release from 19/01/2026, 11:45 CET/CEST - Viromed Medical AG: Ex-vivo lung study marks milestone for research and approval Viromed Medical AG to conduct ex-vivo lung study on vital lungs in cooperation with universities for accelerated research and approval processes Medical Technology Viromed Medical AG Cold Plasma Technology Ex-vivo Lung Study Research Milestone
BRIEF published on 01/19/2026 at 11:50, 3 months 30 days ago Viromed Medical AG fait progresser son étude pulmonaire ex vivo Viromed Medical AG Technologie Du Plasma Froid Étude Pulmonaire Ex Vivo Accélération De La Recherche Préclinique Collaboration De L'Université De La Sarre
BRIEF published on 01/19/2026 at 11:50, 3 months 30 days ago Viromed Medical AG Advances with Ex-Vivo Lung Study Viromed Medical AG Cold Plasma Technology Ex-vivo Lung Study Preclinical Research Acceleration Saarland University Collaboration
PRESS RELEASE published on 01/19/2026 at 11:45, 3 months 30 days ago Viromed Medical AG: Ex-vivo lung study marks milestone for research and approval Viromed Medical AG's ex-vivo lung study with Saarland University and MHH is a significant milestone for research & approval, accelerating development processes Research Approval Viromed Medical AG Cold Plasma Technology Ex-vivo Lung Study
BRIEF published on 01/15/2026 at 09:53, 4 months 3 days ago Viromed Medical AG Transitions to Registered Shares Shareholders Stock Exchange Viromed Medical AG Registered Shares Cold Plasma Technology
BRIEF published on 01/15/2026 at 09:53, 4 months 3 days ago Viromed Medical AG passe aux actions nominatives Actionnaires Bourse Viromed Medical AG Actions Nominatives Technologie Du Plasma Froid
PRESS RELEASE published on 01/15/2026 at 09:48, 4 months 3 days ago Viromed Medical AG switches to registered shares Viromed Medical AG converts share capital from bearer shares to registered shares to enhance transparency and direct shareholder communication. Stock trading to commence under new ISIN DE000A40VZN7 Stock Exchange Transparency Viromed Medical AG Registered Shares Bearer Shares
BRIEF published on 01/07/2026 at 14:20, 4 months 11 days ago Viromed AG Shares Strategic Update on MedTech Advancements Respiratory Diseases Global Partnerships Innovative Medical Devices Viromed Medical AG Cold Plasma Technology
Published on 05/18/2026 at 14:37, 2 hours 27 minutes ago Tyson Fury, The Gypsy King, Joins Datavault AI as International Spokesperson to Champion Athlete Data Monetization
Published on 05/18/2026 at 14:30, 2 hours 34 minutes ago Ebola Global Health Emergency Needs a Broad-Spectrum Drug - NV-387 is a Strong Potential Candidate, Says NanoViricides
Published on 05/16/2026 at 01:15, 2 days 15 hours ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/18/2026 at 16:50, 14 minutes ago Huawei Unveils its Grid-Interactive AIDC Strategy, Shaping the Future of the Industry
Published on 05/18/2026 at 15:50, 1 hour 14 minutes ago BLUETTI at WUF13: Partnering with UN-Habitat to Power Global Sustainable Urbanization
Published on 05/18/2026 at 15:41, 1 hour 22 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 05/18/2026 at 15:40, 1 hour 23 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 05/18/2026 at 15:39, 1 hour 24 minutes ago Form 8.3 - The Vanguard Group, Inc.: Senior plc
Published on 05/18/2026 at 11:06, 5 hours 58 minutes ago GUILLEMOT CORPORATION: Weekly report share buyback From May 11th to May 15th 2026
Published on 05/18/2026 at 11:06, 5 hours 58 minutes ago GUILLEMOT CORPORATION : Déclaration hebdomadaire des transactions sur actions propres du 11 mai 2026 au 15 mai 2026
Published on 05/18/2026 at 08:30, 8 hours 34 minutes ago Thales appoints Jérémie Papin Senior Executive Vice-President, Finance and Information Systems
Published on 05/18/2026 at 08:30, 8 hours 34 minutes ago Thales nomme Jérémie Papin Directeur général, Finance et Systèmes d’Information
Published on 05/15/2026 at 15:08, 3 days 1 hour ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
